STRATEGIES FOR STUDYING BRAIN DISORDERS
Vol.3 Dopamine Disease States
Editors:Tomás Palomo, Richard Beninger, Trevor Archer
August 1996
Publisher: Editorial CYM, General Oráa, 47, 28006 MADRID
ISBN: 84-921848-0-9
Pages: 668
Congresess
International Meeting on Dopamine Disease States
Mojácar (Almería)
October 18 - 22 1995
The content of this congress, together with other contributions on the topic, are collected in vol. 3 of the series "Strategies for studying brain disorders". (The book is also available in Spanish).
PROGRAMME
- Tomás Palomo, Spain.
Opening Remarks. - Erik Clavería, Spain.
Neuroscience research in Spain and in collaboration with other countries.
S1. DOPAMINE-SCHIZOPHRENIA
- Sven-Ove Ögren, Sweden.
The pharmacological profiles of new and awaited anti-psychotic agents. - William Deakin, UK.
Preclinical and clinical evidence for the excitatory amino-acids in schizophrenia. - Bita Moghaddam, USA.
Dopamine-glutamate interactions and Cognitive Deficits. - Jeffrey M. Goldstein, USA.
Pre-clinical tests that predict Clozapine-like atypical antipsychotic actions. - S2. DOPAMINE-PARKINSON'S DISEASE.
- Jogren Scheel-Krüger, Denmark.
Antagonism and reversal of the MPTP biochemical and behavioural effects in rodents and marmosets by NS 2214, a novel dopamine uptake inhibitor. - Trevor Archer, Sweden.
Dopaminergic-glutamatergic balance in the forebrain: functional studies of movement disorders in rats and mice - Juan José López-Lozano, Spain.
Experience with implantation of fetal mesencephalon in Parkinson's Disease: clinical results in 10 grade IV-V patients. - Alberto Portera-Sánchez, Spain.
Epidemiology, etiology and clinical perspectives of parkisonisms.
S3. DOPAMINE-ADDICTION AND NEUROCHEMISTRY
- Lew Seiden, USA.
Methamphetamine (MA) engendered neurotoxicity to dopamine (DA) neurons: mechanism of action. - Javier Fernández-Ruiz, Spain.
Dopaminergic neurons as neurochemical substrates of neurobehavioral effects of marihuana: developmental and adult studies. - Miguel Casas-Brugé, Spain.
Relevance of dopamine systems in chemical addictions. - Peter Kalivas, USA.
Preclinical-clinical aspects of drug-and stress-induced psychosis.
S4. DOPAMINE DISORDER INTERACTIVE STUDIES
- David Jackson, Sweden.
Clozapine: New biochemical and behavioural studies on its mechanism of action. - Jorge Manzanares, Spain.
Kappa opioid receptor regulation of nigrostriatal, mesolimbic, tuberoinfundibular and periventricular-hypophysial dopaminergic neurons in the male rat. - Richard J. Beninger, Canada.
Dopamine D1-like receptors and molecular mechanisms of incentive learning. - Johan Luthman, Sweden.
Functional and neurochemical responses to interventions in the developing dopamine system. - Rik Broekkamp, The Netherlands.
Role of dopamine-serotonin interrelationships in psychotropic drug effects.
S5. DOPAMINE-GENERAL CONSIDERATIONS
- Pierre Sokoloff, France.
Multiple dopamine receptors: their significance for disease states. - Bart Ellenbroek, The Netherlands.
Dopamine and information processing. - Klaus Ebmeier, UK.
Imaging functional change and dopaminergic activity in depression. - Ivan Izquierdo, Brasil.
Synaptic mechanism in hippocampus, amygdala and enthorhinal cortex involved in memory formation, storage and expression.
S6. DOPAMINE DISEASE STATES
- Nancy Andreasen, USA.
Neural substrates of frontal lobe function. - Robin Murray, UK.
Dementia praecox or developmental insanity: a new perspective on an old debate. - George Koob, USA.
Dopamine subtype receptor profiles in reward and abuse. - Tim Crow, UK.
The failure of the dopamine hypothesis and its consequences for the future direction of psychosis research.
Fundación Cerebro y Mente
c/ General Oraa, 47 - 1º E 28006 Madrid, España
Telf: +34 91 561 1267 Fax: +34 91 564 1817
http://www.cermente.com
© 2009 Fundación Cerebro y Mente. All rights reserved.